Verzenio (abemaciclib) - Eli Lilly
GEMMA: Study to Understand Relationship Between Gut Health and Toxicities of Hormonal Breast Cancer Treatment (clinicaltrials.gov) - Sep 29, 2026 - P=N/A | N=20 | Recruiting | Sponsor: University of Chicago | Not yet recruiting ➔ Recruiting | Initiation date: Dec 2026 ➔ Sep 2026 
Enrollment open • Trial initiation date • Breast Cancer • HER2 Breast Cancer • HER2 Negative Breast Cancer • Hormone Receptor Positive Breast Cancer • Oncology • Solid Tumor • ER • HER-2 • PGR
http://clinicaltrials.gov/ct2/show/NCT07553234
 
Sep 29, 2026
 
Prev Next